SCHEMBL6698883

SCHEMBL6698883

Cc1ccc(NC(=O)Nc2ncc(C(C)N=C(N)N)s2)c(N2CCCCC2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.44
MAPT P10636 3/20 0.43
TP53 P04637 2/20 0.43
NPSR1 Q6W5P4 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
CCNE1 P24864 2/20 0.38
CDK2 P24941 2/20 0.38
CDK5 Q00535 2/20 0.38
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPK1 P28482 2/20 0.36
NPC1 O15118 1/20 0.36
ALPL P05186 1/20 0.36
ALPI P09923 1/20 0.36
ALPG P10696 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PIM1 P11309 1/20 0.36
PIM3 Q86V86 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1342694 0.82 POLB (0.47) POLBMAPTTP53NPSR1L3MBTL1
SCHEMBL1343119 0.80 POLB (0.51) POLBMAPTTP53NPSR1L3MBTL1
SCHEMBL1343056 0.80 POLB (0.45) POLBMAPTTP53NPSR1L3MBTL1
SCHEMBL1343201 0.79 POLB (0.48) POLBMAPTTP53NPSR1L3MBTL1
SCHEMBL1342210 0.79 POLB (0.42) POLBMAPTTP53NPSR1L3MBTL1
SCHEMBL2649815 0.79 POLB (0.40) POLBMAPTTP53NPSR1L3MBTL1
SCHEMBL1342902 0.78 POLB (0.41) POLBMAPTTP53NPSR1L3MBTL1
SCHEMBL1343083 0.78 POLB (0.44) POLBMAPTTP53NPSR1L3MBTL1
SCHEMBL6695210 0.78 CCNE1 (0.39) POLBMAPTCCNE1CDK2CDK5
SCHEMBL1343382 0.78 POLB (0.39) POLBMAPTTP53NPSR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040122235-A1 Aryl carbonyl derivatives as therapeutic agents VTV THERAPEUTICS LLC 2004-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122235-A1 Aryl carbonyl derivatives as therapeutic agents GCK, GCKR, PDK2 POLB 3676/4885MAPT 2678/4885TP53 2961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.